Home Healthcare Medical Devices Fluoroscopy and Mobile C-Arms Market

Fluoroscopy and Mobile C-Arms Market Size, Share & Trends Analysis Report By Device Type (Fluoroscopy Systems, Mobile C-Arms), By Application (Orthopedics, Cardiology, Neurology, Oncology, Others), By End-User (Hospitals, Diagnostic Centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: September 17, 2026 | Author: Debashree Bora | Format:

Fluoroscopy and Mobile C-Arms Market Size Analysis

The global fluoroscopy and mobile c-arms market size was valued at USD 4.71 billion in 2025 and is projected to grow from USD 4.90 billion in 2026 to USD 6.71 billion by 2034, registering a CAGR of 4.01% during the forecast period from 2026 to 2034. North America dominated the fluoroscopy and mobile c-arms market with a market share of 38.5% in 2025.

Fluoroscopy and mobile C-arms are medical imaging technologies that provide real-time X-ray images to visualize internal structures and guide diagnostic and surgical procedures. Fluoroscopy systems continuously capture moving images, while mobile C-arms are portable imaging devices with a C-shaped arm that allows flexible positioning around the patient. These technologies are widely used in orthopedics, cardiology, gastroenterology, pain management, and emergency care to support accurate diagnosis, image-guided interventions, and minimally invasive procedures while improving precision and patient safety.

Fluoroscopy and Mobile C-Arms Market Key Takeaways

Global Market Size & Growth

2025 Market Size
USD 4.71 Billion
2026 Market Size
USD 4.90 Billion
2034 Projected Market Size
USD 6.71 Billion
Forecast Period
2026-2034
Base Year
2025
Market CAGR (2026-2034)
4.01%

Regional Insights

Largest Regional Market (2025)
North America
North America Market Share (2025)
38.5%
Fastest-Growing Region
Asia-Pacific
Asia-Pacific CAGR (2026-2034)
7.4%

Segment Insights

By Device Type
Leading Segment
Fluoroscopy Systems
Market Share in 2025 57.6%
By Application
Fastest growing segment
Neurology
CAGR 6.4% (2026-2034)
By End-User
Leading Segment
Hospitals
Market Share in 2025 66.7%
Fluoroscopy and Mobile C-Arms Market Size

Download a Free Sample To learn more about this report.

Fluoroscopy and Mobile C-Arms Market Dynamics

01

Expansion of Mobile Imaging Across Surgical Specialties

Mobile fluoroscopy is used across orthopedic, vascular, urological, neurological, trauma, and other surgical procedures because it provides real-time visualization during interventions. The ability to position a mobile system directly around the operating table makes C-arms useful where immediate intraoperative imaging is required. Expansion into multiple surgical applications is therefore supporting fluoroscopy and mobile c-arms market demand.

For instance, in April 2025, A.T.S. Applicazione Tecnologie Speciali received FDA clearance for its Persona C HR mobile C-arm, which is indicated for multiple surgical applications including orthopedic, vascular, cardiac, thoracic, pain-therapy, and urological procedures.

01

High Equipment and Ownership Costs Can Limit Adoption

Mobile C-arms require substantial investment in imaging hardware, specialized detectors, generators, service contracts, and supporting infrastructure. Advanced systems incorporating higher-resolution imaging, navigation, or three-dimensional capabilities can further increase acquisition and lifecycle costs. These financial requirements can make it difficult for smaller hospitals and facilities with constrained capital budgets to replace older equipment or expand their mobile imaging fleets.

For instance, in June 2025, GE HealthCare expanded its imaging portfolio with the OEC 3D C-arm, adding three-dimensional imaging capabilities to its mobile surgical imaging offering and illustrating the continued development of higher-capability systems within the mobile C-arm segment.

01

Development of Three-Dimensional Mobile Imaging for Complex Procedures

Three-dimensional imaging capabilities are creating opportunities for mobile C-arms to support procedures that require more detailed anatomical visualization than conventional fluoroscopy. Intraoperative 3D imaging can assist with implant positioning, anatomical localization, and procedural verification without necessarily requiring patients to leave the operating room. These capabilities are creating new fluoroscopy and mobile c-arms market opportunities in advanced surgical applications.

For instance, in April 2025, research published in The Spine Journal compared effective radiation doses from intraoperative 3D imaging using mobile and fixed C-arms with CT imaging for lumbar-spine assessment, supporting continued development of optimized intraoperative 3D imaging.

01

Maintaining Image Quality Across Diverse Surgical Conditions

Mobile C-arms must produce diagnostically useful images across different anatomical regions, patient sizes, surgical positions, implants, and operating-room configurations. Variations in anatomy and the presence of metallic instruments or implants can affect image quality and create demands for improved detectors, image processing, positioning, and workflow optimization. Maintaining consistently useful visualization across these conditions remains a technical challenge for manufacturers and clinical teams.

For instance, in September 2025, researchers published work in the Journal of Applied Clinical Medical Physics comparing radiation output and shielding considerations across mobile C-arm systems, highlighting how differences in system characteristics and operating conditions can affect imaging performance and clinical use.

Fluoroscopy and Mobile C-Arms Market Segmentation Analysis

By Device Type

Fluoroscopy Systems Segment Dominated the Fluoroscopy and Mobile C-Arms Market with 57.6% Share in 2025

The fluoroscopy systems segment dominated the global fluoroscopy and mobile C-arms market with a 57.6% share in 2025, driven by the increasing demand for real-time diagnostic imaging and image-guided medical procedures. Fluoroscopy systems enable physicians to visualize internal organs, blood vessels, bones, and soft tissues during minimally invasive interventions, improving procedural accuracy and patient outcomes. Their widespread use across cardiology, orthopedics, gastroenterology, and vascular procedures, along with continuous advancements in digital imaging technology and radiation dose optimization, continues to support the growth of this segment.

The mobile C-arms segment is witnessing steady growth due to their portability, flexibility, and ability to provide high-quality intraoperative imaging across multiple clinical settings. These systems are increasingly used in operating rooms, emergency departments, and ambulatory surgical centers for orthopedic, trauma, pain management, and vascular procedures, allowing healthcare providers to perform image-guided interventions with greater efficiency and precision.

Fluoroscopy and Mobile C-Arms Market Size By Segments

Request Customizationto receive a tailored report.

By Application

Neurology Segment is Projected to Register the Fastest Growth in the Fluoroscopy and Mobile C-Arms Market at a CAGR of 6.4%

The neurology segment is projected to register the fastest growth in the fluoroscopy and mobile C-arms market at a CAGR of 6.4% during 2026–2034, driven by the increasing prevalence of neurological disorders and growing demand for minimally invasive neurovascular procedures. Fluoroscopic imaging plays an important role in spinal surgeries, neurointerventional procedures, and pain management by providing real-time visualization that enhances procedural precision while reducing surgical risks. Ongoing advancements in imaging technology continue to improve the effectiveness of neurological interventions.

The orthopedics segment continues to account for the largest share of the market due to the extensive use of fluoroscopy and mobile C-arms during fracture fixation, joint replacement, trauma surgery, and spinal procedures. The cardiology segment remains a major application area for catheter-based interventions and vascular imaging, while the oncology segment utilizes fluoroscopic guidance during cancer diagnosis and minimally invasive treatment procedures. The other segment supports demand across gastroenterology, urology, pain management, and various surgical specialties requiring real-time imaging guidance.

By End-User

Hospitals Segment Dominated the Fluoroscopy and Mobile C-Arms Market with 66.7% Share in 2025

The hospitals segment dominated the global fluoroscopy and mobile C-arms market with a 66.7% share in 2025, driven by the high volume of diagnostic imaging procedures, surgical interventions, and emergency care services performed in hospital settings. Hospitals continue to invest in advanced fluoroscopy systems and mobile C-arms to support a wide range of specialties, including orthopedics, cardiology, neurology, and vascular surgery. The availability of skilled healthcare professionals, advanced imaging infrastructure, and comprehensive patient care services continues to reinforce the segment's leading position.

The diagnostic centers segment continues to witness steady growth as demand increases for outpatient diagnostic imaging, early disease detection, and cost-effective imaging services. These facilities are expanding their imaging capabilities to improve patient access and reduce hospital workloads. The other segment, including ambulatory surgical centers and specialty clinics, continues to adopt fluoroscopy and mobile C-arm systems to support minimally invasive procedures, improve workflow efficiency, and deliver high-quality patient care across diverse clinical environments.

Fluoroscopy and Mobile C-Arms Market Share By Segments

Speak to an Analystto discuss market opportunities.

Fluoroscopy and Mobile C-Arms Market Regional Outlook

North America Fluoroscopy and Mobile C-Arms Market Analysis

North America accounted for the largest share of the global fluoroscopy and mobile C-arms market, representing 38.5% of total revenue and reaching USD 1.81 billion in 2025. The region continues to lead due to its advanced healthcare infrastructure, growing number of minimally invasive procedures, and widespread adoption of image-guided surgical technologies. Rising investments in diagnostic imaging equipment, increasing healthcare expenditure, and continuous technological advancements are supporting steady market growth.

United States Fluoroscopy and Mobile C-Arms Market Insights

The US market was valued at approximately USD 1.57 billion in 2025, making it the largest contributor in North America. Increasing demand for minimally invasive surgeries, expanding use of advanced imaging systems in hospitals and ambulatory surgical centers, and ongoing investments in healthcare technology continue to strengthen market growth.

Canada Fluoroscopy and Mobile C-Arms Market Insights

Canada's market reached approximately USD 0.24 billion in 2025. Growing adoption of digital imaging technologies, rising healthcare investments, and increasing demand for real-time diagnostic imaging solutions are contributing to steady market growth.

North America Fluoroscopy and Mobile C-Arms Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Fluoroscopy and Mobile C-Ararms Market Analysis

Asia Pacific accounted for 22.8% of the global fluoroscopy and mobile C-arms market, valued at USD 1.07 billion in 2025, and is projected to register the fastest CAGR of 7.4% during the forecast period. Rapid expansion of healthcare infrastructure, increasing access to advanced diagnostic equipment, rising prevalence of chronic diseases, and growing demand for image-guided surgical procedures continue to drive regional market growth. Government investments in healthcare modernization are further accelerating market expansion.

Japan Fluoroscopy and Mobile C-Arms Market Insights

Japan's market generated approximately USD 0.19 billion in 2025. The country's advanced healthcare system, increasing adoption of minimally invasive procedures, and continuous investment in diagnostic imaging technologies continue to support market growth.

China Fluoroscopy and Mobile C-Arms Market Insights

China accounted for the largest share of the Asia Pacific market, reaching approximately USD 0.62 billion in 2025. Expanding hospital infrastructure, increasing healthcare spending, growing demand for high-quality diagnostic imaging, and rising adoption of mobile C-arm systems continue to drive market expansion.

Europe Fluoroscopy and Mobile C-Arms Market Analysis

Europe represented 27.4% of the global fluoroscopy and mobile C-arms market, reaching USD 1.29 billion in 2025, and is projected to grow at a CAGR of 5.2% during the forecast period. The regional market is supported by increasing demand for advanced medical imaging systems, expanding adoption of minimally invasive surgical techniques, and continuous investments in healthcare infrastructure. Growing emphasis on early disease diagnosis and precision-guided interventions continues to support long-term market growth.

United Kingdom Fluoroscopy and Mobile C-Arms Market Insights

The UK market was valued at approximately USD 0.28 billion in 2025. Rising investments in diagnostic imaging equipment, growing demand for minimally invasive procedures, and continued modernization of healthcare facilities are supporting market expansion.

Germany Fluoroscopy and Mobile C-Arms Market Insights

Germany's market accounted for approximately USD 0.35 billion in 2025. The country's strong medical technology sector, increasing use of image-guided procedures, and ongoing investments in advanced imaging equipment continue to strengthen market growth.

Middle East & Africa Fluoroscopy and Mobile C-Arms Market Analysis

Middle East & Africa accounted for 5.0% of the global fluoroscopy and mobile C-arms market, totaling USD 0.24 billion in 2025. Increasing healthcare investments, expanding hospital infrastructure, and rising demand for advanced diagnostic imaging systems are supporting market growth across the region. Growing access to specialized surgical procedures is expected to create additional opportunities during the forecast period.

UAE Fluoroscopy and Mobile C-Arms Market Insights

The UAE market was valued at approximately USD 0.05 billion in 2025. Government investments in modern healthcare facilities, increasing adoption of advanced imaging technologies, and growing demand for minimally invasive procedures continue to support market development.

Africa Fluoroscopy and Mobile C-Arms Market Insights

Africa's market reached approximately USD 0.19 billion in 2025. Improving healthcare infrastructure, expanding access to diagnostic imaging services, increasing investments in medical equipment, and rising demand for advanced surgical technologies are creating long-term growth opportunities across the region.

List of Key and Emerging Players in Fluoroscopy and Mobile C-Arms Market

General Electric Company
Koninklijke Philips N.V.
Siemens Healthcare Private Limited
Canon Medical Systems Corporation
Shimadzu Corporation
Carestream Health
Hitachi, Ltd.
Hologic, Inc.
Varex Imaging
Ziehm Imaging GmbH
OrthoScan, Inc.
DMS Group
ITALRAY
Nova Biomedical
Augmedics

Key Industry Developments

May 2026
Siemens Healthineers launched the next-generation Cios Spin mobile C-arm system featuring advanced 3D imaging, AI-assisted workflows, and enhanced intraoperative visualization for orthopedic, trauma, and spine procedures.
April 2026
GE HealthCare expanded its OEC mobile C-arm portfolio by introducing AI-powered imaging enhancements and improved workflow automation for surgical and interventional imaging applications.
February 2026
Philips introduced an upgraded Zenition mobile C-arm platform with enhanced image quality, lower radiation dose, and cloud-enabled connectivity to improve surgical imaging efficiency.
October 2025
Canon Medical Systems expanded its fluoroscopy imaging portfolio by launching a new digital fluoroscopy system with advanced dose reduction technologies and improved real-time image processing.

Report Scope

Segmentation

By Device Type 2
  • Fluoroscopy Systems
  • Mobile C-Arms
By Application 5
  • Orthopedics
  • Cardiology
  • Neurology
  • Oncology
  • Others
By End-User 3
  • Hospitals
  • Diagnostic Centers
  • Others

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage General Electric Company · Koninklijke Philips N.V. · Siemens Healthcare Private Limited · Canon Medical Systems Corporation · Shimadzu Corporation
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The fluoroscopy and mobile c-arms market size is valued at USD 4.90 Billion in 2026 and is projected to reach USD 6.71 Billion by 2034, at a CAGR of 4.01% during the forecast period 2026-2034.
North America dominated the market with a share of 38.5% in 2025.
The leading players in this market are General Electric Company, Koninklijke Philips N.V., Siemens Healthcare Private Limited, Canon Medical Systems Corporation, Shimadzu Corporation.
The fluoroscopy and mobile c-arms market is projected to grow at a CAGR of 4.01% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
Trusted by Industry Leaders
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now